Monday, 20 April 2015
Claris settles litigation with Fresenius Kabi on Diprivan drugs
Drug-maker Claris Lifesciences today said it has settled ‘litigation and licence agreement’ with US-based Fresenius Kabi to sell generic version of anesthesia drug, Diprivan, in the US.
from News Nation http://ift.tt/1DCmESG
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment